Reimagining Clinical Trial Surplus: Harnessing Donations to Close the Global Healthcare Gap
Supply Chain, Sustainability
Clinical trials often generate excess supplies that go unused and have to be discarded. This paper proposes a structured donation model to repurpose these materials ethically and efficiently, supporting underserved healthcare systems. It highlights efforts like Kits4Life and MedSurplus Alliance, and calls for regulatory reform and greater awareness to promote sustainability and social responsibility in clinical trial supply management.
Related Education Resources.
All ResourcesExpanded Access: Past, Present and Future Improvements
Topics: Additional Concepts, Closeout, EAP, Execution, Forecasting / Planning
Position Paper
Free
Video on eTMF Requirements provided by Steve Jacobs, Chairman at Global BioPharm Solutions.
Topics: Pharma Industry, Strategic Planning
Video
Members
The Exponential Growth of Decentralized Trials, Direct-to-Patient and the Future of the Clinical Trials Landscape in Europe
Topics: Conference, Regulatory
Executive Summary
Members
